Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT(N) framework: defining abnormal neurodegeneration and improving prediction of clinical status

BACKGROUND: Alzheimer’s disease involves accumulating amyloid (A) and tau (T) pathology, and progressive neurodegeneration (N), leading to the development of the AD clinical syndrome. While several markers of N have been proposed, efforts to define normal vs. abnormal neurodegeneration based on neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallagher, Rigina L., Koscik, Rebecca Langhough, Moody, Jason F., Vogt, Nicholas M., Adluru, Nagesh, Kecskemeti, Steven R., Van Hulle, Carol A., Chin, Nathaniel A., Asthana, Sanjay, Kollmorgen, Gwendlyn, Suridjan, Ivonne, Carlsson, Cynthia M., Johnson, Sterling C., Dean, Douglas C., Zetterberg, Henrik, Blennow, Kaj, Alexander, Andrew L., Bendlin, Barbara B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583332/
https://www.ncbi.nlm.nih.gov/pubmed/37848950
http://dx.doi.org/10.1186/s13195-023-01281-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583332/
https://www.ncbi.nlm.nih.gov/pubmed/37848950
http://dx.doi.org/10.1186/s13195-023-01281-y

Ejemplares similares